Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
CareDx
CDNA
$2.34B
| $696K | ﹤0.01% |
24,109
+21,212
| +732% | +$397K |
|
3927
CALL
MBIA
MBI
$264M
| $694K | ﹤0.01% |
64,900
+31,100
| +92% | +$318K |
|
3928
CALL
Franklin Resources
BEN
$17.2B
| $693K | ﹤0.01% |
22,800
+3,400
| +18% | +$110K |
|
3929
PUT
iShares MSCI Germany ETF
EWG
$1.68B
| $693K | ﹤0.01% |
23,300
+4,600
| +25% | +$139K |
|
|
DNKN
3930
PUT
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $693K | ﹤0.01% |
9,400
-900
| -9% | -$65K |
|
3931
PUT
Clorox
CLX
$12.8B
| $692K | ﹤0.01% |
4,600
-24,100
| -84% | -$3.42M |
|
3932
Monarch Casino & Resort
MCRI
$2.22B
| $692K | ﹤0.01% |
15,220
+6,118
| +67% | +$284K |
|
|
HA
3933
PUT
DELISTED
Hawaiian Holdings, Inc.
HA
| $690K | ﹤0.01% |
17,200
-10,900
| -39% | -$433K |
|
|
AQUA
3934
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $690K | ﹤0.01% |
38,784
+33,237
| +599% | +$651K |
|
|
PTLA
3935
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $687K | ﹤0.01% |
25,800
+25,400
| +6,350% | +$829K |
|
3936
America Movil
AMX
$70.3B
| $685K | ﹤0.01% |
42,713
+24,496
| +134% | +$413K |
|
|
RST
3937
DELISTED
ROSETTA STONE INC
RST
| $684K | ﹤0.01% |
34,415
+29,672
| +626% | +$482K |
|
|
BID
3938
PUT
DELISTED
Sotheby's
BID
| $684K | ﹤0.01% |
13,900
+8,700
| +167% | +$440K |
|
|
RVNC
3939
DELISTED
Revance Therapeutics, Inc.
RVNC
| $682K | ﹤0.01% |
27,398
+14,988
| +121% | +$408K |
|
|
ASXC
3940
DELISTED
Asensus Surgical, Inc.
ASXC
| $682K | ﹤0.01% |
9,046
+3,707
| +69% | +$251K |
|
|
AIMT
3941
CALL
DELISTED
Aimmune Therapeutics
AIMT
| $682K | ﹤0.01% |
+25,000
| New | +$707K |
|
3942
Atlanta Braves Holdings Series B
BATRK
$3.44B
| $681K | ﹤0.01% |
25,004
+17,154
| +219% | +$447K |
|
3943
Five Point Holdings
FPH
$371M
| $681K | ﹤0.01% |
72,305
-340
| -0.5% | -$3.74K |
|
3944
QuinStreet
QNST
$1.18B
| $681K | ﹤0.01% |
50,255
+23,321
| +87% | +$330K |
|
3945
PUT
Logitech
LOGI
$14.8B
| $680K | ﹤0.01% |
15,200
+15,100
| +15,100% | +$701K |
|
|
LLL
3946
CALL
DELISTED
L3 Technologies, Inc.
LLL
| $680K | ﹤0.01% |
3,200
-5,000
| -61% | -$1.04M |
|
|
3947
PUT
Franklin Resources
BEN
$17.2B
| $678K | ﹤0.01% |
22,300
-1,900
| -8% | -$61.2K |
|
3948
PUT
C.H. Robinson
CHRW
$17.4B
| $676K | ﹤0.01% |
6,900
-2,700
| -28% | -$253K |
|
|
SRCL
3949
PUT
DELISTED
Stericycle Inc
SRCL
| $675K | ﹤0.01% |
11,500
-6,200
| -35% | -$396K |
|
|
INSY
3950
DELISTED
Insys Therapeutics, Inc.
INSY
| $675K | ﹤0.01% |
66,901
-40,380
| -38% | -$322K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.